We are Abzena. More than a CDMO, we are a responsible and dedicated Partner Research Organization (PRO) that takes care of your products from concept to patient. With extensive experience in developing biologics and bioconjugates, we offer a seamless service delivered by fully integrated teams, from early discovery to commercial manufacturing.
Forward-thinking and committed, we find the best solution and use the right technologies to design, develop and manufacture your products to ensure we get vital medicines to patients quickly and safely. We are dedicated to quality excellence. We are driven to get better treatments to market, efficiently and responsibly by reducing timelines and delivering the highest quality products and services.
Our CRDMO platform provides a one-stop solution for API and drug product from discovery through commercial for oligonucleotide, peptide, and complex conjugates. Chemistry powerhouse across platforms supports novel conjugates such Oligo-GalNAc, Oligo-Toxin, PPMO, PDC, etc. Manufacturing cabability covers all oligos categories from µmol to mol scale as well as monomers and ligands such as amidite and GalNAc. Peptide synthesis includes long linear & cyclic peptides, modified peptide with 2500+ unnatural amino acids category product available.
MabPlex International provides one-stop, high-quality CRO/CMO solutions for biologics (mAb and ADCs) to our global clients. We are dedicated to help our clients accelerate development process and reduce manufacture costs. MabPlex has extensive experiences in manufacturing for therapeutic antibodies and antibody-drug conjugates (ADCs). Our manufacturing facilities with large-scale disposable lines and world-class instruments are operated by well-trained professionals in full compliance with U.S, European, and Chinese GMP regulations.
Theratechnologies is a biopharmaceutical company focused on the development and
commercialization of innovative therapies addressing unmet medical needs.
We currently market prescription products in the United States, Europe and Canada. Our
research pipeline focuses on specialized therapies addressing unmet medical needs in HIV,
oncology and NASH.
MilliporeSigma is the leading Life Science company, providing solutions to help advance the promise of life saving therapies. We have the largest innovative offering of products and services to support our bioconjugation partners. With a 1,000 ft2 expansion of our clinical conjugation facility (St. Louis, Mo) in 2021 and a 70,000 ft2 expansion of our HPAPI manufacturing facility (Madison, Wi) in 2022, we are the CDMO partner that novel conjugate customers can trust to take them throughout the development and manufacturing journey and to serve their future needs.
Goodwin Delivers from Gene Sequence to Drug Product
On Time. On Budget. In Compliance.
Goodwin Biotechnology’s mission is to eliminate the manufacturing risk for companies developing complex biologic therapeutics by being the pre-eminent provider of high-quality, cost-effective, flexible and timely cGMP compliant manufacturing solutions, from pre-clinical development through commercial product supply. By integrating our services in one location, Goodwin provides a Single Source Solution™ to anticipate and overcome the challenges you face with your biopharmaceutical candidate, whether it be complex proteins such as monoclonal antibodies or a sophisticated Antibody Drug Conjugate (ADC).